Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rule 8.3- Tepnel Life Sciences Plc

3rd Feb 2009 15:09

RNS Number : 7250M
Pendragon Capital LLP
03 February 2009
 
FORM 8.3
 
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the Takeover Code)
 
1. KEY INFORMATION
 
Name of person dealing (Note 1)
Pendragon Capital LLP
Company dealt in
Tepnel Life Sciences Plc
Class of relevant security to which the dealings being disclosed relate (Note 2)
1p Ordinary
Date of dealing
Feb 2nd 2009
 
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
 
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 
 
Long
 
Short
 
 
Number
(%)
Number
(%)
(1) Relevant securities
 
 
 
 
(2) Derivatives (other than options)
4,075,000
1.70
 
 
(3) Options and agreements to purchase/sell
 
 
 
 
Total
4,075,000
1.70
 
 
 
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
 
Class of relevant security:
Long
 
Short
 
 
Number
(%)
Number
(%)
(1) Relevant
 
 
 
 
(2) Derivatives (other than options)
 
 
 
 
(3) Options and agreements to purchase/sell
 
 
 
 
Total
 
 
 
 
 
(c) Rights to subscribe (Note 3)
 
Class of relevant security:
Details
 
 
 
3. DEALINGS (Note 4)
 
(a) Purchases and sales
 
Purchase/sale
Number of securities
Price per unit (Note 5)
 
 
 
 
(b) Derivatives transactions (other than options)
Product name, e.g. CFD
 
Long/short (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)
CFD
Long
 
500,000
 
26.25p
 
 
c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
 
Product name,e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc.
Expiry date
Option money paid/received per unit (Note 5)
 
 
 
 
 
 
 
 
(ii) Exercising
 
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5) 
 
 
 
 
(d) Other dealings (including new securities) (Note 4)
 
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
 
 
 
 
4. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 
………………………NONE……………………………
 
……………………………………………………………………
 
 
Is a Supplemental Form 8 attached? (Note 9) NO
 
 
Date of disclosure
Feb 3rd 2009
Contact name
John Pennells
Telephone number
020 7907 8445
If a connected EFM, name of offeree/offeror with which connected
 
If a connected EFM, state nature of connection (Note 10)
 
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel’s website at www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUORVRKBRURAR

Related Shares:

TED.L
FTSE 100 Latest
Value8,275.66
Change0.00